Article
Genetic testing for Parkinson's disease in clinical practice.
Journal of neural transmission (Vienna, Austria : 1996) - 1 Jun 2023
Gasser Thomas
Abstract excerpt
The identification of disease-causing mutations or strong risk factors for Parkinson's disease in genes encoding proteins such as α-synuclein (SNCA), leucine-rich repeat kinase-2 (LRRK2), or glucocerebrosidase (GBA1) has led to a better understanding of the different components of disease pathogenesis. Many gene and mutation-specific targeted disease-modifying treatments are under development and several studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
